Europlasma S.A. buy krebskrebs
Start price
25.01.21
/
50%
€18,400
Target price
25.01.22
€100,000
Performance (%)
-94.46%
End price
26.01.22
€1,020.0
Summary
This prediction ended on 26.01.22 with a price of €1,020.0. Massive losses of -94.46% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Europlasma S.A. | - | - | - | - |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % | 44,61 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % | 70,74 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % | 48,21 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % | 54,25 % |
Comments by krebskrebs for this prediction
In the thread Europlasma S.A. diskutieren
In the thread Trading Europlasma S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten